Skip to main content
Log in

Haemodynamic effects of macrocyclic and linear gadolinium chelates in rats: role of calcium and transmetallation

  • Published:
Biometals Aims and scope Submit manuscript

Abstract

Several studies were undertaken to compare four magnetic resonance imaging (MRI) contrast media (CM) as regards acute haemodynamic effects in rats and to investigate the mechanisms involved. (1) Normotensive rats received a rapid bolus intravenous injection of 0.5 mmol kg of each CM. The effects of Gd-DOTA, Gd-HP-DO3A, Gd-DTPA and Gd-DTPA-BMA on blood pressure (BP) were compared. (2) The haemo-dynamic effects of Gd-DTPA (0.5 mmol kg ) were compared to those of isovolumic and isoosmolar Zn-DTPA and glucose solutions. (3) The haemodynamic profiles of Gd-DTPA and Gd-DTPA-BMA were recorded with and without addition of ionized calcium. (4) The mechanism of Gd-HP-DO3A-induced tran-sient rise in BP was investigated by evaluating the effects of phentolamine or diltiazem pretreatment. For (1) the greatest drop in BP occurred following Gd-DTPA (a linear chelate) injection (–18 ± 2% vs base-line, P < 0.01). Gd-DTPA-BMA, another lineate chelate, also induced a slight but significant reduction in BP (–8 ± 2% at 45 s, P < 0.05). Gd-DOTA, a macrocyclic CM, had virtually no haemodynamic effects. For (2) the Gd-DTPA-induced drop in BP was greater than that of the osmolality-matched glucose control and lower than that of osmolality-matched Zn-DTPA. For (3) a transmetallation phenomenon versus free ionized calcium is possible in the case of both linear CM (Gd-DTPA and Gd-DTPA-BMA) since Ca significantly reduced the CM-induced decrease in BP. For (4) a transient rise in BP was observed following Gd-HP-DO3A, another macrocyclic chelate, associated with a concomitant increase in stroke volume. This effect was antagonized neither by phentolamine nor by diltiazem. The decrease in BP following injection of Gd-DTPA or Gd-DTPA-BMA may not only be osmolality-related since (a) Gd-DOTA solution, whose osmo-lality is greater than that of Gd-DTPA-BMA, had a lesser effect, and (b) this hypotensive effect was corrected by addition of ionized calcium. The transient Gd-HP-DO3A-induced rise in BP is probably the consequence of a positive inotropic effect. © Rapid Science 1998

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Akre BT, Dunkel JA, Hustvedt SO, Refsum H. 1997 Acute cardiotoxicity of gadolinium-based contrast media: findings in the isolated rat heart. Acad Radiol 4, 283–291.

    Google Scholar 

  • Anonymous 1989 In: Reynolds JEF ed. Martindale, The Extra Pharmacopoeia, London: The Pharmaceutical Press; 1023.

    Google Scholar 

  • Bainbridge PA. 1915 Influence of venous filling upon rate of the heart. J Physiol London 50, 65–84.

    Google Scholar 

  • Balériaux D, Matos C, De Greef D. 1993 Gadodiamide injection as a contrast medium for MRI of the central nervous system: a comparison with gadolinium-DOTA. Neuroradiol 35, 490–494.

    Google Scholar 

  • Bokenes J, Hustvedt SO, Refsum H. 1997 Comparison of cardiovascular changes after administration of gadodiamide injection and gadopentetate dimeglumine in dogs. Acad Radiol 4, 204–209.

    Google Scholar 

  • Bourne GW, Trifaro JM. 1982 The gadolinium ion: a potent blocker of calcium channels and catecholamine release from cultured chromaffin cells. Neurosci 7, 1615–1622.

    Google Scholar 

  • Cacheris WP, Quay SC, Rocklage SM. 1990 The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Reson Imaging 8, 467–481.

    Google Scholar 

  • Corot C, Hentsch AM, Curtelin L. 1994 Interaction of gadolinium complexes with metal-dependent biological systems. Invest Radiol 29, S164-S167.

    Google Scholar 

  • Evans CH. 1990 Biochemistry of the Lanthanides. New York: Plenum Press.

    Google Scholar 

  • Fukuda S, Yamagiwa J, Iida H. 1986 Effect of intravenously injected DTPA on cardiovascular system in rats. Hoken Butsuri 21, 245–250.

    Google Scholar 

  • Geschwind JFH, Saeed M, Wendland MF, Szolar D, Derugin N, Higgins CB. 1996 Acute hemodynamic effects of recently developed monomer and dimer magnetic resonance imaging contrast media: a comparative study. Acad Radiol 3, 667–677.

    Google Scholar 

  • Gross DR. 1994 Animal Models in Cardiovascular Research. Dordrecht: Kluwer Academic Publ.

    Google Scholar 

  • Harpur ES, Worah D, Hals PA, Holtz E, Furuhama K, Nomura H. 1993 Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent. Invest Radiol 28, S28-S43.

    Google Scholar 

  • Hattner R, White D. 1990 Gallium/stable gadolinium antagonism: MRI contrast agent markedly alters the normal biodistribution of gallium-67. J Nucl Med 31, 1844–1846.

    Google Scholar 

  • Hieronim DE, Kanal E, Swanson DP. 1995 Dosage of gadoteridol and adverse reactions relative to gadopentetate. Am J Health-Syst Pharm 52, 2556–2559.

    Google Scholar 

  • Kasokat T, Urich K. 1992 Quantification of dechelation of gadopentetate dimeglumine in rats. ArzneimittelForsch 42, 869–876.

    Google Scholar 

  • Krasnow N. 1972 Effects of lanthanum and gadolinium ions on cardiac sarcoplasmic reticulum. Biochim Biophys Acta 282, 187–194.

    Google Scholar 

  • Langer GA. 1990 Calcium exchange and contractile control. In: Langer GA. ed. Calcium and the Heart. New York: Raven Press; 355–378.

    Google Scholar 

  • Lauffer RB. 1987 Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem Rev 87, 901–927.

    Google Scholar 

  • Li HT, Saeed M, Wendland MF, Higgins CB. 1993 Cardiovascular responses after ionic and nonionic magnetic resonance contrast media in rats with acute myocardial infarction. Invest Radiol 28, 11–19.

    Google Scholar 

  • Masui T, Takehara Y, Aoshima R, Kaneko M. 1995 Acute hemodynamic effects of intravenous bolus injection of ionic and nonionic magnetic resonance contrast media. Acad Radiol 2, 148–153.

    Google Scholar 

  • Milliken GA. 1990 Analysis of repeated measures design. In: Berry DA. ed. Statistical Methodology in the Pharmaceutical Sciences. New York: Dekker; 83–116.

    Google Scholar 

  • Mühler A, Saeed M, Brasch RC, Higgins CB. 1992a Hemodynamic effects of bolus injection of gadodiamide and gadopentetate dimeglumine as contrast media at MR imaging in rats. Radiology 183, 523–528.

    Google Scholar 

  • Mühler A, Saeed M, Brasch RC, Higgins CB. 1992b Amelioration of cardiodepressive effects of gadopentate dimeglumine with addition of ionic calcium. Radiology 184, 159–164.

    Google Scholar 

  • Niendorf HP, Brasch RC. 1993 Gd-DTPA tolerance and clinical safety. In: Brasch RD ed. MRI Contrast Enhancement in the Central Nervous System: A Case Study Approach. New York: Raven Press, pp 11–21.

    Google Scholar 

  • Oksendal A, Hals PA. 1993 Biodistribution and toxicity of MR imaging contrast media. J Magn Reson Im 3, 157–165.

    Google Scholar 

  • Pang SC, Scott TM. 1980 Use of the common carotid artery in blood pressure measurement in rats. A possible source of error. Can J Physiol Pharmacol 58, 1126–1127.

    Google Scholar 

  • Puttagunta NR, Gibby WA, Smith GT. 1996a Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents. Invest Radiol 31, 739–742.

    Google Scholar 

  • Puttagunta NR, Gibby WA, Puttagunta VL. 1996b Comparative transmetallation kinetics and thermodynamic stability of gadolinium DTPA bis-glucosamide and other magnetic resonance imaging contrast media. Invest Radiol 31, 619–624.

    Google Scholar 

  • Rinck PA. 1993 Magnetic Resonance in Medicine. The Basic Textbook of the European Magnetic Resonance Forum. Oxford: Blackwell.

    Google Scholar 

  • Runge VM, Wells JW. 1995 Update: safety, new applications, new MR agents. Top Magn Res Imaging 7, 181–195.

    Google Scholar 

  • Rushmer RF. 1970 Cardiovascular Dynamics. Philadelphia: W.B. Saunders.

    Google Scholar 

  • Scott EM. 1983 Reflex control of the cardiovascular system and its modification. Some implications for pharmacologists. J Auton Pharmacol 3, 113–126.

    Google Scholar 

  • Triggle DJ. 1996 The classification of calcium antagonists. J Cardiovasc Pharmacol 27, S11-S16.

    Google Scholar 

  • Tweedle MF. 1991 Nonionic or neutral? Radiology 178, 891.

    Google Scholar 

  • Tweedle MF, Wedeking P, Kumar K. 1995 Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats. Invest Radiol 30, 372–389.

    Google Scholar 

  • VanWagoner M, O'Toole M, Worah D, Leese PT, Quay SC. 1991 A phase I clinical trial with gadodiamide injection, a nonionic magnetic resonance imaging enhancement agent. Invest Radiol 26, 980–986.

    Google Scholar 

  • Waynforth HB. 1980 Experimental and Surgical Technique in the Rat. London: Academic Press.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Idée, JM., Berthommier, C., Goulas, V. et al. Haemodynamic effects of macrocyclic and linear gadolinium chelates in rats: role of calcium and transmetallation. Biometals 11, 113–123 (1998). https://doi.org/10.1023/A:1009225911668

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009225911668

Navigation